The factors that drive the growth of the anesthesia machinery market include technological advancements in anesthesia monitoring, rise in number of surgical procedures and increase in geriatric population. However, high cost of installation and maintenance and regulatory compliance restrain the growth of the anesthesia machinery market. Furthermore, rise in demand for quality healthcare monitoring and untapped emerging markets are anticipated to provide lucrative opportunities for anesthesia machine manufacturers in the future.

The report provides market dynamics and trends related to the blood market. It includes revenue generated from the sales of products, which are used to collect and process different components of blood such as source plasma, albumin, and hyperimmune serum. The products which are covered in the report include whole blood collection systems, whole blood collection reagents, source plasma collection systems, source plasma collection reagents, and others. The blood market is segmented into product, end user, and region. On the basis of product, it is classified into whole blood collection and processing, source plasma collection, blood typing products, and blood screening products. Furthermore, all these segments are further classified into sub-segments. For instance, the whole blood collection segment is classified into whole blood collection systems and whole blood collection consumables. The source plasma collection segment is classified into source plasma collection systems and source plasma collection consumables. In addition, the blood typing products are further bifurcated into blood typing systems, blood typing reagents. The blood screening products are divided into blood screening systems, and blood screening reagents.

The report provides dynamics and trends related to the global clinical nutrition market. In addition, it presents the estimations and forecast of the market. Moreover, the study estimates revenue generated from the sales of clinical nutrition products. The revenues are confined to the clinical nutrition options to maintain health. These products aid to improve the metabolic system of the body by providing adequate supplements such as minerals, vitamins, and others.

The current market for cervical cancer diagnostics is growing at a healthy rate, which is primarily attributed to the increasing involvement of the government organizations in cervical cancer screening programs and increasing burden of the disease across the world. PAP and HPV tests are vital for diagnosis of cervical cancer. Mostly these tests are performed together for the patient age group between 21-65 years. As per the International Agency for Research on Cancer, more than 85% of cervical cancers patients are from the developing countries, which demands better efficacy screening and treatment programs for women health. Since the cancer progression is slow and may take up to 20 years to develop into an advanced stage, there are many opportunities to stop the disease before it becomes fatal. At present, there are many cities in the emerging market that lack resources for a good laboratory with highly trained cytotechnicians and other specialized staff, which is among the major challenge for good results from Pap testing. With the advancement in HPV tests, the possibility of preventing the cervical cancer has increased even in the low-resource countries (developing countries) because HPV tests are becoming more affordable. Along with that, cost-effective strategies are being implemented by the countries to leverage self-sampling.

The global continuous glucose monitoring (CGM) systems market is segmented based on component, end user, demographics, and geography. The report includes the revenue generated from the sale of various continuous glucose monitoring systems, but excludes the revenue generated by dealers, traders, or brokers involved in the supply of the systems.Diabetes, a chronic lifestyle disease, is classified into type 1 and type 2 diabetes. In type 1 diabetes, the pancreas is unable to produce sufficient or requisite amount of insulin hormone that is required for metabolizing glucose. In type 2 diabetes, the pancreas produces insulin, but the cells lack the ability to respond and/or do not uptake the insulin available in the blood stream. The symptoms of diabetes include:

One of the major factors driving the growth of the companion diagnostic market is the increasing demand for personalized medicines and awareness about the same among the population. With companies increasing their collaborations for better biomarkers and diagnostics to focus on cost regulations, there have been significant number of oppor tunities for their application in indications other than in cancer, like cardiovascular and neurological. The high rise in capital is the basis for the prosperous future of this market. Companion diagnostics is becoming an indispensable part of personalized medicine and is expected to gain prominence in therapeutics used for the treatment of various diseases. The use of companion diagnostics is taking up a central role as an important treatment decision tool for a number of oncology drugs, and it is also reflected in the way the FDA classifies these assays in relation to risk. In the United States, companion diagnostics assays are classified as IVD class III products, representing a highrisk category, and consequently the highest level of regulatory control.

A laparoscope comprises a long, thin tube with high intensity light along with high resolution camera in front. The camera transmits images to monitor as it travels through the abdomen. Laparoscopy is used for diagnosis as well as treatment of endometriosis, ectopic pregnancy, pelvic inflammatory disease (PID), cysts, and fibroids. The report includes the revenue generated from all devices used for laparoscopic procedures, and the revenue generated by laparoscope device manufacturers. Revenue generated by clinics or hospital services provided to patients through use of laparoscope devices is excluded from the market, as this revenue, known as service cost, is earned by respective hospitals and clinics among end users.

Blood bank is a place where blood is collected, separated, processed, tested, and stored for future use. In addition, a blood bank provides red blood cells, whole blood, blood plasma, blood platelet and other blood products to the healthcare providers. The report provides market dynamics and trends related to the global blood bank market. In addition, it presents the market estimations and forecast. The study estimates the revenue generated from blood services provided by blood banks such as blood collection, processing, testing, storage, and distribution. A blood banks distributes blood and blood components to hospitals4, ambulatory surgery centers, pharmaceutical companies, clinics & nursing homes, and others. However, the report does not include revenue generated from blood banking devices as well as plasma derivatives and other blood products.

The global Alzheimer ’s disease (AD) diagnostics and therapeutics market is currently composed of five major marketed drugs, donepezil, galantamine, rivastigmine, memantine, and combination of donepezil/memantine; a multitude of brain imaging diagnostics tests; and a highly invasive technique of CSF analysis for AD biomarker identification. The end product/service offered in this market today is the same as what was offered about a decade ago. During the last decade, there were many drugs that made it to the late stages of clinical trials, but almost all of them were rejected for market approval, due to toxicity and safety issues. Today, many drugs are again in the late pipeline stages of drug development for AD. In fact, there are more candidates than ever and there are many novel drug applicants, aimed at addressing the actual pathological cause of AD, which the currently marketed drugs are unable to address. Additionally, the current modality in advanced and late AD diagnosis is composed of brain imaging studies, which sometimes need to be conducted over a wide timespan of months to arrive at the correct diagnosis. The second line of diagnosis is composed of CSF tests, which requires an invasive procedure of lumbar puncture.

Biomarker can be defined as a naturally occurring gene, molecule, or a characteristic that can be quantitatively analyzed and assessed as an indicator of a pathogenic, normal biological, or a pharmacological response to a therapeutic intervention. Biomarkers are identified by diagnostic processes, assays, and certain interventions. Any anomaly identified in the biomarker indicates the presence of a disease such as cancer; thus, this process can be quantified and interrelated with disease, health, or drug treatment. The cancer biomarkers market report covers revenue generated from sales of instruments used in cancer biomarker diagnostic procedures. However, applications of cancer biomarkers in research, clinical trials, drug development, drug validation, risk assessment, and drug formulation are excluded from the scope of this report. The report also excludes revenue generated from services provided by physicians in the cancer biomarker diagnostics procedures.

The stretch marks treatment market is largely driven by the rising burden of obesity can result in an exponential rise in stretch marks. Lifestyle-related disorders are found having a great influence on the body. Avoiding alcohol, drugs, exercising, and following a healthy diet aid in staying healthy. For instance, as per the WHO it was stated that most of the world's population live in countries where overweight and obesity kill more people than underweight. These factors indicate that there is a high burden of obesity in the world, which is augmenting the number of people having stretch marks. Moreover, there are approximately 44% of unplanned pregnancy cases in Europe and 38% in Asia, which may lead to high growth of the stretch marks treatment market, due to the rising number of pregnancy cases. Because the stretch marks are associated with gestational change that affects between 50% to 90% of women, depending on the race and age of the population. Many women develop stretch marks during their first pregnancy.

The NPWT market is currently being driven by factors, such as the rising prevalence of chronic wounds and growing diabetic population. This leads to a higher number of diabetic foot ulcers and increase in the geriatric population across the world. Few factors are hindering the market growth, which includes the high cost of the NPWT therapy, and complications associated with NPWT devices. The market is witnessing continuous advancements in the products and technologies used. Companies, such as 3M (Acelity LP Inc.), Smith & Nephew, and ConvaTec Group PLC, hold large market shares, in the NPWT devices. Single-use NPWT products are gaining popularity over traditional products in the area of wound care treatment. For example, key players, like Smith & Nephew, have launched a single-use NPWT, PICO, which has gained tremendous popularity, worldwide. Fur ther, ConvaTec Inc. launched the Avelle™ Negative Pressure Wound Therapy (“NPWT”) system. It is the first and only device of this technology, combining negative pressure with the advantages of Hydrofiber® technology. Thus, advancements in technology in negative pressure wound therapy products may drive the market growth, during the forecast period.

The report provides market dynamics and trends related to the global anti-viral therapies market. In addition, it presents the market estimations and forecast. The study estimates the revenue generated from the sales of the drugs and therapies approved for the treatment of viral infections. The valuations comprise revenue generated from usage of drugs and therapies, in HIV, herpes, hepatitis, and influenza. However, the report does not include revenue generated by dealers, traders, or brokers of the market.

Burns are injuries to tissues or skin caused by radiation, heat, friction, chemicals, or electricity. Burn care treatment includes relieving pain, maintaining body fluids & electrolytes, preventing infection, and calorie intake during the healing process. The report provides market dynamics and trends related to the global burn care market. In addition, it presents the estimations and forecast of the market. The valuations comprise revenue generated from burn care products such as advanced burn care, biologics, traditional burn care, and others. The study estimates the revenue generated from the sales of burn care products; however, it excludes the burn care service revenue. Furthermore, the report excludes revenue generated from post-sale services of burn care products.

The report provides an in-depth analysis of fungicides consumption in different types of crops such as cereal &grains, oilseed &pulses, fruits &vegetables, and others. It also provides the production of different types of fungicides such as dithiocarbamates, benzimidazoles, chloronitriles, triazoles, phenylamides, strobilurins, and others. The other fungicides include morpholines and anilinopyrimidines. The market analysis and estimations are done in terms of revenue and volume of the fungicides. The report provides information on revenues and volume of production for all geographies, types of fungicides, and types of crops. The revenue of global fungicides includes the revenues of synthetic fungicides and biofungicides.

Infectious disease rapid diagnostic testing is primarily adopted for the diagnosis of various infectious diseases in a restricted clinical environment. These testing primarily relies on the detection of the target analyte, offering clinical insights in a stipulated time frame. Such testing is becoming an integral component of the healthcare system across the globe. The adoption of these tests in the healthcare system has aided clinicians in navigating through tough times during the outbreak of highly contagious infections, such as Ebola virus disease (EVD), SARS-CoV, Middle East respiratory syndrome coronavirus (MERS-CoV), and COVID-19.

The dengue testing market is currently showing a healthy growth due to the increase in incidences of dengue cases. Change in climate is likely to increase the burden of dengue fever further. In addition, increasing awareness campaigns to educate about the ills of dengue are boosting the market growth. The overall incidence of dengue, as well as the explosive outbreaks of dengue, has been increasing dramatically over the past several years. According to the World Health Organization, the number of cases reported increased from 2.2 million in 2010 to over 3.34 million in 2016, and it is still on the rise. Although the full global burden of the disease is uncertain, the initiation of activities to record all dengue cases par tly explains the sharp increase in the number of cases repor ted in recent years. Therefore, not only the number of cases is increasing as the disease spreads to new areas, but better diagnostics and documentation of outbreaks is occurring as well.

Biocides are products or chemicals that combat pests or microorganisms. These are generally used to control and kill harmful and unwanted organisms such as mold, bacteria, algae, insects, and rodents. Biocides represent various products such as disinfectants, wood preservatives, rodenticides, antifouling agents (on boats), in-can preservatives, used in homes, public places such as hospitals, and industries. Biocide preservation applications are leading the market, accounting for the largest consumption of specialty biocides in both volume and value terms. Despite regulatory pressures, reducing the number of biocides depending on their concentrations in end products, blends of carefully selected biocidal active substances in optimal ratios, coupled with new technical advancements can provide improved preservation solutions without the need for cautionary labeling.

The dental sterilization market is primarily driven by increasing prevalence of dental ailments, such as edentulism, dental caries, and others coupled with the rising demand for cosmetic dentistry owing to its broadening applications. In dentistry, it is very important to have an effective and efficient way of controlling any type of infection, in order to ensure the patient’s wellbeing. Disinfection and sterilization are essential to prevent transmission of infectious pathogens to patients and staff. There are number of programs on infection control that spread awareness about sterilization and cleaning of dental devices and instruments. According to the Global Burden of Disease Study estimates, in 2017, oral diseases affected arounnd 3.5 billion people worldwide, with caries of permanent teeth being the most common condition. globally.